We reviewed 90+ equity crowdfunding platforms and prepared a list of the hottest (in our opinion) startups you can invest starting from a few hundred euros!
We produce plant-based fish and meat alternatives using our specially developed industrial 3D food printing process.
Learn more – Watch video
Industry - 3D printed food production
Rasing – 1500000 EUR
Raised – 1192106 EUR
Valuation (pre-money)- 15000000 EUR
Estimated value/ growth - Total 5,75 - 7,28 x
Company and product stage
Post revenue
What problem company is solving?
The global fish stock is 30% overfished and 60% completely depleted. The resulting destruction of marine ecosystems harbours the risk of the collapse of the largest ecosystem on our planet. A catastrophe for humans, animals and the environment.
In the summer of 2023, we brought the world's first 3D-printed food product, a vegan salmon filet, to the supermarket. In the next step, we plan to scale up our production and produce 60,000 salmon filets per month by Q3 2024. We have already received enquiries from some of the largest supermarket chains in Europe, which even exceed our initial capacity.
Will the team be able to deliver?
Team of young professionals covering all main areas, product, production, sales, and marketing.
What is the market potential?
Our current market and target group is the B2C business, where we particularly address flexitarians. One in three European consumers now describe themselves as flexitarians. In Germany, this figure is as high as 42%.
Artscapy is the award-winning alternative investment platform for Art. Art is one of the largest and best performing collectable asset in the world, beating classic cars, watches, and fine wine. It even beats the stock market.
Learn more – Watch video
Industry- Investing in art
Rasing - 650,009 GBP
Raised - 617,029 GBP
Valuation (pre-money)- 12.9 M GBP
Company and product stage
Product ready with active users and the company has a turnover of 0,5 million.
What problem Artscapy is solving and what is market potential?
Artscapy is opening up the $68 billion art market, delivering access to both novice and seasoned collectors and investors through intuitive technology. Our platform eliminates entry barriers, simplifies complex terminology, and eradicates hidden fees prevalent in the art world, enabling individuals to effortlessly unite their passion for art with wealth accumulation.
Imagine the modern bank account and all the savvy, user-friendly features it now comes with. Now apply that to art. That is Artscapy.
Will the Artscapy team be able to deliver?
The team of the company has already reached good results - £150M of artworks managed, and 6,000+ members which indicates the team's ability to deliver and develop products.
First mover in neurotherapy: VR therapy method to promote cognitive abilities in neuronal diseases.
Learn more – Watch video
Industry – Healthcare
Rasing - 750,000 EUR
Raised- 695,945 EUR
Valuation (pre-money)- 10,600,000 EUR
Estimated value/ growth- Targeted total return 306% (4 years)
Company and product stage
Over the past two years, the Living Brain has been able to further develop its product portfolio to include strategically important components and thus create the infrastructure required for future growth. In addition to teora mind, the software application that allows people with cognitive impairments to train activities relevant to https://livingbrain.de/en/everyday life safely and controllably in virtual reality, this now also includes the new elements teora platform and teora supervisor.
What problem company is solving?
VR neurotherapy is significantly superior to the gold standard living brain has launched teora® mind, a new therapy for neurorehabilitation that uses VR technology to make immersive everyday training available to patients anywhere and at any time. The special thing about it is that patients use VR glasses to complete everyday tasks in a virtual environment and thus train everyday activities, memory, concentration and attention in a targeted manner. A clinical study has demonstrated the effectiveness of this therapy method, showing that it is significantly superior to the previous gold standard therapy: 6 times greater improvement in complex attention, 14 times greater improvement in problem solving and 14 times greater improvement in health status.
What is the market potential?
The brain training market size is estimated to reach USD 9.53 billion in 2023 and is expected to reach USD 56.73 billion by 2031. This corresponds to a growth of 25.3% CAGR during the forecast period for 2024-2031.1
Will the team be able to deliver?
The founding team consists of CEO Barbara Stegmann, Chief Science Officer Julian
Specht and CTO Till Ikemann. Barbara Stegmann is a psychologist and has focussed on entrepreneurial processes and company development right from the start. In 2023, she won the Digital Female Leader Award in the field of digital health. During her studies, she worked together with her fellow student Julian Specht to found living brain. As a sufferer himself, Julian Specht experienced how unsuitable the current treatment methods in neurorehabilitation are and, together with Barbara Stegmann, was motivated to develop a more effective therapy method. Julian Specht is a business psychologist and has a deep understanding of the underlying neurosciences. Till Ikemann joined the founding team in May 2019 and, as an experienced game developer specializing in virtual reality, is responsible for the technical development of the product. In the last two years, the team has grown from 6 to 11 employees (with a fluctuation of 0). The lack of experience in sales development is still critical, especially for the planned ramp-up.
Hello - we are BLOCKHEAD, a company that aims to turn a very ordinary chewing gum - into something extraordinary. BLOCKHEAD brings a fresh flex to the functional food market through chewing gum. We make gum that can give you a caffeine boost in 5 minutes, a moment of calm anywhere, or a CBD hit.
Rasing- 500,000 GBP
Raised- 231,530 GBP
Valuation (pre-money)- 4,000,000GBP
Company and product stage
The company already made sales. 2 million pieces of gum sold.
What problem company solving?
Problem: Modern life is faster and more demanding than ever. We expect things immediately. No hassle, no thinking. Constantly looking for more from everything we do. More productive. Healthier.
Solution. Chewing gum is a remarkable delivery mechanism, delivering functional benefits in 5 mins compared to the 25 for drinks or pills. Convenient, enjoyable, calorie, and sugar-free.
Will the team be able to deliver?
A strong management team consists of experts from main key areas – product, sales, marketing.
What is the market potential?
The functional market is colossal. The global functional drinks market worth $204bn. The global wellness market is worth $6.6 trillion and UK chewing gum market £356m
We are digitalizing the future customer service and experience ecosystem for Automotive, leasing and insurance industries and connecting all stakeholders through a All in One industry agnostic digital platform with mobile applications.
Learn more: Watch video
Industry – Fintech Leasing
Rasing - 110.000 EUR
Raised - 46.000 EUR
Valuation (pre-money) - 3.000.000 EUR
Company and product stage
The company is in post revenue stage.
What problem company is solving?
Problem: Vehicle and customer management in the automotive and car insurance industries is analog! E-mail and Viber chats are perceived as a digitalization still, with customer experience mediocre at best. Customers are struggling through an analogue, archaic and time-consuming processes, with no digital interaction with their service providers.
Businesses in the automotive and car insurance industries are operationg in silos with no partner and user/customer interaction visibility and transaprency which limits them in meeting the needs of the next generation of vehicle users, and service prefrences like car sharing and mobility as a service.
As stated by latest market Analisys by Deloitte - The future of automotive mobility to 2035
“ 50%–60% of future profits of mobility providers may be at stake if they continue their business as usual.” Deloitte Global Automotive Mobility Market Simulation Tool.
Solution: All-in-one scalable SaaS solution for vehicle business stakeholders that enables complete digital customer service and experience for the end customer through mobile applications, and digital open ecosystem for communication and interaction between businesses.Cars Central enables subscriptions, online payments, digital service books and history, tyre management, remote insurance claims, Mobility-as-a-Service, with features for additional revenues through cross-selling.Business can leverage the platform for online payments, driver self-service, transparency, cost reporting and tracking, digital road book, enquiries with approvals etc.
What is the market potential?
The total vehicles on the road globally are c. 1.6bn, behind them is an eco-system of insurance providers, fleet operators, leasing companies, service chains, repair and tyre shops etc. All of these businesses will benefit from using Cars Central and becoming part of our platform.
We estimated that there are as many as 6-7 million potential clients for Cars Central in the EU alone, which at 2,700 euros p.a. per license leads to a €16 bn market size.
Our goal is to reach 20-30,000 license clients by 2030.
Pumpinheart on Spark
Pumpinheart is a Pre-revenue Royal College of Surgeons in Ireland spin-out developing a 'cath lab' implantable heart pump to treat advanced stage diastolic Heart Failure.
Learn more: Watch Video
Industry- MedTech, implantable heart pump
Rasing - 500,000 EUR
Raised -130,025 EUR
Valuation (pre-money)- 3,000,000 EUR
Company and product stage
The company is at pre-clinical research stage so there are no commercial revenues
What problem company is solving
HFpEF is an unmet medical need. HFpEF patients comprise more than 50% of the total number of HF patients.
This diastolic HF cohort is growing at 1% per year due to the increasein population age, increase in obesity and the number of survivors of Cardiac Arterial Disease (CAD).
HFpEF patients are typically obese hypertensives or frail diabetics and predominantly female (female : male ratio of 2 : 1).
In the USA, Canada, UK & EU the cost of direct medical care of HF patients will grow to over $100B in 2030 with the majority of these being HFpEF patients. Globally, there are more than 18M HFpEF patients reliant on drug therapy that does not improve mortality. Primary market research indicates the immediate addressable market for ‘PReduction’ is 29% of Stage C or D HFpEF patients, that is estimated to be 640k HFpEF patients in the USA and Europe.
Will the team be able to deliver?
Strong team with significant industry experience.
What is the market potential?
Pumpinheart is addressing an unmet medical need for approximately 640,000 Advanced Stage Diastolic Heart Failure patients suitable for implant in the US and Europe.
This category of heart failure patients experiences high rehospitalization rates with the cost of direct medical care estimated to cost $100 billion per annum in the US and Europe alone by 2030. Pumpinheart’s Serviceable Addressable Market (SAM) is expected to be $32 billion.
We are developing Energy Ships that produce green hydrogen on board by electrolysis on the open ocean to bring it back to harbors.
Learn more – Watch video
Industry: Green energy - green hydrogen production
Rasing -2.000.000 EUR
Raised- 408.461 EUR
Valuation (pre-money) - 25.000.000 EUR
Estimated value/ growth- Total 5,75 - 7,28 x
Company and product stage
Prototype
Will the team be able to deliver?
Experience team of product experts and engineers.
What is the market potential?
Global hydrogen demand is forecasted to reach 21,500 TWh per year by 2050
Remember: Direct and indirect investment in crowdfunding involves significant risks as there is a potential risk for loss of part or all of the invested capital.
Find more investment opportunities at Crowdinform.com
We wish you a good day and successful investing!